Zynerba Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZYNE and other ETFs, options, and stocks.

About ZYNE

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on the research and development of rare and near-rare neuropsychiatric conditions. 

CEO
Armando Anido
CEOArmando Anido
Employees
28
Employees28
Headquarters
Devon, Pennsylvania
HeadquartersDevon, Pennsylvania
Founded
2007
Founded2007
Employees
28
Employees28

ZYNE Key Statistics

Market cap
39.16M
Market cap39.16M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
413.72K
Average volume413.72K
High today
$0.88
High today$0.88
Low today
$0.85
Low today$0.85
Open price
$0.85
Open price$0.85
Volume
197.54K
Volume197.54K
52 Week high
$4.62
52 Week high$4.62
52 Week low
$0.82
52 Week low$0.82

ZYNE Earnings

-$0.33
-$0.22
-$0.11
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.